来自Huperzia serrata的Lycopodium类化合物及其胆酶抑制活性
Shuai Jiang1, Bei-Bei Gao1, Yu-Fei Ou1
1State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, People's Republic of China; University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China.
胡佩尔齐亚塞拉塔 (Huperzia serrata) 产生了具有胆酶抑制作用的新型基化物. 超氨酸G显示出作为潜在的阿尔茨海默病治疗向乙胆化酶的承诺.
科学领域:
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 传统上,Huperzia serrata用于治疗疼痛和炎症.
- 这种植物含有具有胆化酶抑制潜力的Lycopodium类化合物.
研究的目的:
- 鉴定和描述来自H. serrata. 的基化物.
- 评估分离化合物的胆化酶抑制活性.
主要方法:
- 使用HRESIMS,NMR,ECD和X射线衍射进行隔离和结构阐明.
- 通过修改的埃尔曼方法进行胆酶抑制试验 (AChE和BuChE).
主要成果:
- 已分离出16种基,包括10种新化合物 (超氨酸AG,I-K) 和一种新天然产物 (超氨酸H).
- 胡拉丁G (7) 显示出强大的乙胆酶抑制 (IC50 = 0.876 μM).
- 化合物1显示了中度的乙胆酶抑制 (IC50 = 13.125 μM).
结论:
- 超氨酸G是一种有前途的化合物,用于开发新型乙胆酶抑制剂.
- 这项研究扩大了已知的H. serrata类化合物的化学多样性.
- 建议对阿尔茨海默氏症的潜在治疗应用.
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...


